1. Home
  2. NAMS vs GPOR Comparison

NAMS vs GPOR Comparison

Compare NAMS & GPOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • GPOR
  • Stock Information
  • Founded
  • NAMS 2019
  • GPOR 1997
  • Country
  • NAMS Netherlands
  • GPOR United States
  • Employees
  • NAMS N/A
  • GPOR N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • GPOR Oil & Gas Production
  • Sector
  • NAMS Health Care
  • GPOR Energy
  • Exchange
  • NAMS Nasdaq
  • GPOR Nasdaq
  • Market Cap
  • NAMS 2.3B
  • GPOR 2.7B
  • IPO Year
  • NAMS N/A
  • GPOR N/A
  • Fundamental
  • Price
  • NAMS $20.12
  • GPOR $177.61
  • Analyst Decision
  • NAMS Strong Buy
  • GPOR Buy
  • Analyst Count
  • NAMS 6
  • GPOR 7
  • Target Price
  • NAMS $33.80
  • GPOR $179.33
  • AVG Volume (30 Days)
  • NAMS 634.7K
  • GPOR 241.4K
  • Earning Date
  • NAMS 11-06-2024
  • GPOR 11-05-2024
  • Dividend Yield
  • NAMS N/A
  • GPOR N/A
  • EPS Growth
  • NAMS N/A
  • GPOR N/A
  • EPS
  • NAMS N/A
  • GPOR 11.88
  • Revenue
  • NAMS $33,594,000.00
  • GPOR $886,642,000.00
  • Revenue This Year
  • NAMS N/A
  • GPOR $5.77
  • Revenue Next Year
  • NAMS N/A
  • GPOR $25.53
  • P/E Ratio
  • NAMS N/A
  • GPOR $14.95
  • Revenue Growth
  • NAMS 78.77
  • GPOR N/A
  • 52 Week Low
  • NAMS $8.90
  • GPOR $119.75
  • 52 Week High
  • NAMS $26.35
  • GPOR $182.94
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 44.60
  • GPOR 77.99
  • Support Level
  • NAMS $19.59
  • GPOR $158.18
  • Resistance Level
  • NAMS $25.32
  • GPOR $166.48
  • Average True Range (ATR)
  • NAMS 1.44
  • GPOR 4.61
  • MACD
  • NAMS -0.32
  • GPOR 2.58
  • Stochastic Oscillator
  • NAMS 36.35
  • GPOR 88.47

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About GPOR Gulfport Energy Corporation

Gulfport Energy Corp is an independent natural gas-weighted exploration and production company focused on the exploration, acquisition and production of natural gas, crude oil and NGL in the United States. It operates through Utica Shale and Scoop properties. The Utica Shale is located in the Appalachian Basin of the United States and Canada. The Scoop (South Central Oklahoma Oil Province) play of Oklahoma is located in the southeast portion of the prolific Anadarko Basin.

Share on Social Networks: